Brief: Tenax Therapeutics Announces USPTO Grants Notice Of Allowance For U.S. Patent Application
06/02/2024 14:30
Feb 6 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS ANNOUNCES USPTO GRANTS NOTICE OF
ALLOWANCE
FOR U.S. PATENT APPLICATION, SIGNIFICANTLY BROADENING IP
PROTECTION FOR USE OF LEVOSIMENDAN IN PULMONARY HYPERTENSION
WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFPEF)
Source text for Eikon: ID:nGNX8fKS4
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))